← Open Payments lookup

DAVID BOEL: Open Payments

NPI 1780091793 · NEPHI, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,033 in 44 payments from 10 companies in 2025. Trend: 2023 $505 · 2024 $546 · 2025 $1,033

Food & beverage: $914Education: $119
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.9$272
Neurocrine BioSciences, Inc.8$177
Alkermes, Inc.8$145
Axsome Therapeutics, Inc.4$111
Braeburn Inc.2$88
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$81
ABBVIE INC.4$66
Lundbeck LLC2$43
E.R. Squibb & Sons, L.L.C.2$29
Indivior Inc.1$21

Products named: INGREZZA, AUSTEDO XR, ARISTADA, Auvelity, BRIXADI, CAPLYTA, VRAYLAR, REXULTI.

Industry payments across UT — which companies pay providers there.